← Glossary

Clearance (CL)

See also: volume-of-distributionhalf-lifepharmacokineticsauc

Clearance is the volume of plasma from which a substance is completely removed per unit time. It represents the efficiency with which the body eliminates a substance through metabolism and excretion, and is a fundamental parameter in pharmacokinetics.

Key Concepts

  • Elimination Rate: Clearance quantifies how rapidly the body removes a substance
  • Physiological Basis: Reflects the combined efficiency of all elimination organs and pathways
  • Intrinsic vs. Measured: Can be estimated from physiological processes or derived from concentration-time data

Units of Measurement

Clearance is expressed as volume per unit time:

  • Common units: mL/min, L/h, or mL/min/kg (normalized to body weight)
  • Represents a theoretical volume cleared, not an actual physical volume

Mechanisms of Clearance

Substances are cleared through multiple pathways:

  • Hepatic Clearance: Metabolism by liver enzymes (e.g., cytochrome P450 for small molecules; peptidases for peptides)
  • Renal Clearance: Excretion through urine via glomerular filtration, tubular secretion, or reabsorption
  • Pulmonary Clearance: Exhalation through breath (less common for most compounds)
  • Other Pathways: Minor clearance through bile, saliva, or other fluids

Types of Clearance

  • Total Body Clearance (CL): Sum of clearance from all organs and pathways
  • Hepatic Clearance (CLh): Portion of clearance attributable to liver metabolism
  • Renal Clearance (CLr): Portion of clearance attributable to kidney elimination
  • Unbound Clearance: Clearance of only the free (unbound) fraction, important for highly protein-bound substances

Calculation Methods

Clearance can be determined through several approaches:

  • Non-Compartmental Analysis: CL = Dose / AUC (for IV administration)
  • With Bioavailability: CL = (Dose × F) / AUC (for extravascular administration, where F is bioavailability)
  • Compartmental Modeling: CL is estimated as a model parameter from concentration-time data

Factors Influencing Clearance

  • Organ Function: Reduced liver or kidney function decreases clearance
  • Blood Flow: Organ perfusion affects delivery of substance to elimination sites
  • Enzyme Activity: Genetic variation, induction, or inhibition of metabolic enzymes
  • Protein Binding: Only unbound molecules are available for clearance mechanisms
  • Age and Development: Clearance varies with age, especially in pediatric and geriatric populations
  • Pathophysiology: Disease states can significantly alter clearance

Relationship to Other PK Parameters

Clearance is mathematically related to other key pharmacokinetic parameters:

  • Half-life: Half-life = (0.693 × Volume of Distribution) / Clearance
  • AUC: AUC = Dose / Clearance (for IV administration)
  • Steady-State Concentration: Concentration at steady state depends on clearance and dosing rate

Clearance in Peptide Research

Peptide clearance often differs from small molecules:

  • Enzymatic Degradation: Peptides are frequently cleared by peptidases in blood and tissues
  • Rapid Clearance: Many peptides have short half-lives due to high clearance
  • Modification Effects: Chemical modifications (e.g., PEGylation, fatty acid conjugation) often aim to reduce clearance
  • Species Differences: Peptide clearance can vary dramatically between animal models and humans
  • Route Dependence: Clearance may vary by administration route due to different exposure to degradation enzymes

Clinical vs. Research Context

Clearance values differ between settings due to:

  • Purity and formulation differences between research-grade and clinical compounds
  • Species-specific metabolism (animal models vs. humans)
  • Assay sensitivity and sampling methodology
  • Pathophysiological differences in study populations

Limitations and Considerations

  • AUC Dependency: Accurate clearance determination requires complete AUC calculation
  • Linearity Assumptions: Clearance may not be constant across all concentrations (saturation effects)
  • Individual Variation: Significant inter-individual variability in clearance is common
  • Steady-State vs. Single-Dose: Clearance can differ after repeated administration due to enzyme induction or changes in physiology

Note: Clearance describes the rate of elimination, not how long a substance remains in the body. A substance can have high clearance but still persist for a long time if it distributes widely (high volume of distribution), or have low clearance but be eliminated quickly if confined to a small volume.